Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Immunology|August 6, 2013
Toll-like receptor 3 in viral pathogenesis: friend or foe?Renzo Perales-Linares, Sonia Navas-Martin
FEBS Letters|August 19, 2014
Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6Gokul Swaminathan, Daniel Pascual, Germaine Rival, et al.
Oncoimmunology|December 7, 2017
Trial watch: DNA-based vaccines for oncological indicationsStefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
"Tumor-to-endothelium mitochondrial transfer licenses endothelial cells for CD8 + T cell recognition via mitochondrial neoantigen presentation"Francesca Costabile, Pierini Stefano, Renzo Perales-Linares, et al.
Journal for Immunotherapy of Cancer|February 10, 2021
Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progressionStefano Pierini, Abhishek Mishra, Renzo Perales-Linares, et al.
Blood Advances|August 30, 2024
Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltrationNektarios Kostopoulos, Francesca Costabile, Elisavet Krimitza, et al.
The Journal of Clinical Investigation|December 10, 2019
Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune responseMireia Uribe-Herranz, Stavros Rafail, Silvia Beghi, et al.
Cancer Research|August 14, 2023
Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy ResistanceRenzo Perales-Linares, Nektaria Maria Leli, Hesham Mohei, et al.
Nature Medicine|April 7, 2024
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trialMark Yarchoan, Edward J Gane, Thomas U Marron, et al.
Nature Cancer|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialElizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Pageof 1